Table 1.
Exercise sessions per week | ||||||
---|---|---|---|---|---|---|
1 (n = 16) | 2 (n = 15) | 3 (n = 14) | 4 (n = 17) | 5 (n = 16) | ANOVA P‐value | |
Body weight (kg) | 76.6 ± 5.8 | 76.8 ± 4.8 | 77.7 ± 5.7 | 77.8 ± 8.8 | 79.8 ± 5.9 | 0.654 |
Hct (%) | 43.8 ± 2.3 | 43.4 ± 1.6 | 43.9 ± 2.1 | 43.0 ± 1.6 | 43.5 ± 2.2 | 0.752 |
Hb (g dl−1) | 14.6 ± 0.7 | 14.4 ± 0.6 | 14.9 ± 0.7 | 14.8 ± 0.6 | 14.5 ± 0.8 | 0.229 |
Hbmass (g) | 847 ± 84 | 878 ± 151 | 826 ± 103 | 841 ± 113 | 761 ± 101 | 0.064 |
PV (ml) | 3266 ± 532 | 3440 ± 501 | 3077 ± 376 | 3246 ± 453 | 2976 ± 430 | 0.065 |
RBCV (ml) | 2521 ± 262 | 2640 ± 452 | 2408 ± 299 | 2454 ± 362 | 2288 ± 301 | 0.070 |
BV (ml) | 5787 ± 772 | 6080 ± 935 | 5486 ± 637 | 5700 ± 792 | 5264 ± 696 | 0.054 |
MitoVD (%)a | 4.62 ± 1.42 | 4.80 ± 1.14 | 4.89 ± 1.09 | 3.86 ± 0.91 | 4.32 ± 1.21 | 0.169 |
HRmax (bpm) | 188 ± 5 | 185 ± 7 | 187 ± 7 | 188 ± 6 | 187 ± 7 | 0.736 |
RERmax | 1.15 ± 0.05 | 1.15 ± 0.09 | 1.17 ± 0.06 | 1.13 ± 0.05 | 1.14 ± 0.07 | 0.510 |
(ml min−1) | 3214 ± 507 | 3412 ± 736 | 3376 ± 438 | 3449 ± 514 | 2956 ± 435 | 0.069 |
(ml min−1 kg−1) | 42.4 ± 8.5 | 44.7 ± 10.7 | 43.4 ± 4.2 | 44.5 ± 5.8 | 37.4 ± 7.5 | 0.057 |
W max (W) | 269 ± 44 | 289 ± 66 | 297 ± 42 | 266 ± 48 | 239 ± 403 | 0.015 |
W max (W kg−1) | 3.54 ± 0.70 | 3.80 ± 0.95 | 3.82 ± 0.45 | 3.42 ± 0.48 | 3.02 ± 0.6123 | 0.008 |
BV, blood volume; Hbmass, haemoglobin mass; Hct, haematocrit; HRmax, maximal heart rate; MitoVD, mitochondrial volume density; PV, plasma volume; RBCV, red blood cell volume; RERmax, maximal respiratory exchange ratio; , maximal oxygen consumption; W max, maximal power output. Superscript numbers (1, 2, 3, 4, 5) correspond to differences (P < 0.05) between groups (1, 2, 3, 4, 5). aMitoVD values were not available in all study subjects (sample size of 15, 14, 11, 15, 14 in groups 1, 2, 3, 4 and 5, respectively). Values in bold are significant.